• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在患有慢性肾病的大鼠中,整个骨骼都不同程度地出现皮质骨孔隙。

Cortical porosity occurs at varying degrees throughout the skeleton in rats with chronic kidney disease.

作者信息

Metzger Corinne E, Newman Christopher L, Tippen Samantha P, Golemme Natalie T, Chen Neal X, Moe Sharon M, Allen Matthew R

机构信息

Department of Anatomy, Cell Biology, and Physiology, Indianapolis, IN, USA, 46202.

Department of Radiology and Imaging Sciences, Indianapolis 46202, IN, USA.

出版信息

Bone Rep. 2022 Aug 17;17:101612. doi: 10.1016/j.bonr.2022.101612. eCollection 2022 Dec.

DOI:10.1016/j.bonr.2022.101612
PMID:36035656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9411579/
Abstract

Cortical porosity develops in chronic kidney disease (CKD) and increases with progressing disease. Cortical porosity is likely a prominent contributor to skeletal fragility/fracture. The degree to which cortical porosity occurs throughout the skeleton is not fully known. In this study, we assessed cortical bone porosity via micro-computed tomography at multiple skeletal sites in rats with progressive chronic kidney disease. We hypothesized that cortical porosity would occur in long bones throughout the body, but to a lesser degree in flat bones and irregular bones. Porosity was measured, using micro-CT, at 17 different skeletal sites in 6 male rats with CKD. Varying degrees of porosity were seen throughout the skeleton with higher porosity in flat and irregular bone (i.e. parietal bone, mandible) vs. long bones (p = 0.01) and in non-weightbearing bones vs. weightbearing bones (p = 0.01). Porosity was also higher in proximal sites vs. distal sites in long bones (p < 0.01 in all comparisons). There was large heterogeneity in porosity within skeletal sites across rats and within the same rat across skeletal sites. Correlations showed cortical porosity of the proximal tibia was positively associated with porosity at the other sites with the strongest correlation to the parietal bone and the weakest to the ulna. Overall, our data demonstrates varying and significant cortical bone porosity across the skeleton of animals with chronic kidney disease. These data point to careful selection of skeletal sites to assess porosity in pre-clinical studies and the potential for fractures at multiple skeletal sites in patients with CKD.

摘要

皮质骨孔隙率在慢性肾脏病(CKD)中会出现,并随着疾病进展而增加。皮质骨孔隙率很可能是导致骨骼脆弱/骨折的一个重要因素。目前尚不完全清楚整个骨骼中皮质骨孔隙率出现的程度。在本研究中,我们通过显微计算机断层扫描评估了进行性慢性肾脏病大鼠多个骨骼部位的皮质骨孔隙率。我们假设全身长骨都会出现皮质骨孔隙率,但扁骨和不规则骨中的程度较轻。使用显微CT对6只患有CKD的雄性大鼠的17个不同骨骼部位进行了孔隙率测量。在整个骨骼中都观察到了不同程度的孔隙率,扁骨和不规则骨(即顶骨、下颌骨)中的孔隙率高于长骨(p = 0.01),非负重骨中的孔隙率高于负重骨(p = 0.01)。长骨近端部位的孔隙率也高于远端部位(所有比较中p < 0.01)。大鼠之间以及同一大鼠的不同骨骼部位之间,骨骼部位内的孔隙率存在很大异质性。相关性分析表明,胫骨近端的皮质骨孔隙率与其他部位的孔隙率呈正相关,与顶骨的相关性最强,与尺骨的相关性最弱。总体而言,我们的数据表明,患有慢性肾脏病的动物整个骨骼中皮质骨孔隙率各不相同且差异显著。这些数据表明,在临床前研究中评估孔隙率时要谨慎选择骨骼部位,并且CKD患者多个骨骼部位存在骨折的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/02ca6bce1f14/mmc3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/51c9d918de2c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/85f66ecd02ec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/09a544c58cf3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/1ecb9fa8439f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/eba1f46ae171/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/c706e86179e7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/6618db3ca540/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/9350c713b637/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/38c1507cab12/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/268a87ebf051/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/ec2ecac00134/mmc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/c8a6f1fc1c1e/mmc2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/02ca6bce1f14/mmc3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/51c9d918de2c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/85f66ecd02ec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/09a544c58cf3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/1ecb9fa8439f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/eba1f46ae171/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/c706e86179e7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/6618db3ca540/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/9350c713b637/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/38c1507cab12/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/268a87ebf051/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/ec2ecac00134/mmc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/c8a6f1fc1c1e/mmc2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c37/9411579/02ca6bce1f14/mmc3.jpg

相似文献

1
Cortical porosity occurs at varying degrees throughout the skeleton in rats with chronic kidney disease.在患有慢性肾病的大鼠中,整个骨骼都不同程度地出现皮质骨孔隙。
Bone Rep. 2022 Aug 17;17:101612. doi: 10.1016/j.bonr.2022.101612. eCollection 2022 Dec.
2
Assessing cortical bone porosity with MRI in an animal model of chronic kidney disease.用 MRI 评估慢性肾脏病动物模型的皮质骨多孔性。
Bone. 2023 Aug;173:116808. doi: 10.1016/j.bone.2023.116808. Epub 2023 May 18.
3
Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease.在慢性肾病动物模型中,依替卡肽治疗后皮质孔隙的发展和进展得到缓解。
Bone. 2022 Apr;157:116340. doi: 10.1016/j.bone.2022.116340. Epub 2022 Jan 24.
4
Combining raloxifene and mechanical loading improves bone composition and mechanical properties in a murine model of chronic kidney disease (CKD).雷洛昔芬联合机械加载改善慢性肾脏病(CKD)小鼠模型的骨组成和力学性能。
Bone. 2024 Jun;183:117089. doi: 10.1016/j.bone.2024.117089. Epub 2024 Apr 3.
5
Time course of rapid bone loss and cortical porosity formation observed by longitudinal μCT in a rat model of CKD.CKD 大鼠模型中纵向 μCT 观察到的快速骨丢失和皮质多孔性形成的时程。
Bone. 2019 Aug;125:16-24. doi: 10.1016/j.bone.2019.05.002. Epub 2019 May 3.
6
CKD Stages, Bone Metabolism Markers, and Cortical Porosity Index: Associations and Mediation Effects Analysis.CKD 分期、骨代谢标志物与皮质骨孔隙指数:关联与中介效应分析。
Front Endocrinol (Lausanne). 2021 Nov 5;12:775066. doi: 10.3389/fendo.2021.775066. eCollection 2021.
7
Kidney Disease and Bone: Changing the Way We Look at Skeletal Health.肾脏疾病与骨骼:改变我们看待骨骼健康的方式。
Curr Osteoporos Rep. 2020 Jun;18(3):242-246. doi: 10.1007/s11914-020-00580-9.
8
Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats.去卵巢对 Cy/+ 雌性大鼠慢性肾脏病-矿物质骨异常(CKD-MBD)进展的影响。
Sci Rep. 2019 May 28;9(1):7936. doi: 10.1038/s41598-019-44415-9.
9
Longitudinal Evolution of Bone Microarchitecture and Bone Strength in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures-A 5-Year Follow-Up Study Using High Resolution Peripheral Quantitative Computed Tomography.2 型糖尿病绝经后女性脆性骨折史与无微结构和骨强度的纵向演变:一项使用高分辨率外周定量计算机断层扫描的 5 年随访研究。
Front Endocrinol (Lausanne). 2021 Mar 16;12:599316. doi: 10.3389/fendo.2021.599316. eCollection 2021.
10
Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study.甲状旁腺抑制治疗可使慢性肾脏病引起的皮质骨血管灌注升高恢复正常:一项初步研究。
Osteoporos Int. 2019 Aug;30(8):1693-1698. doi: 10.1007/s00198-019-04974-z. Epub 2019 May 8.

引用本文的文献

1
Prolonged secondary hyperparathyroidism in adenine-induced CKD leads to skeletal changes consistent with skeletal hyporesponsiveness to PTH.腺嘌呤诱导的慢性肾脏病中,长期继发性甲状旁腺功能亢进会导致骨骼变化,与骨骼对甲状旁腺激素反应低下一致。
PLoS One. 2025 May 23;20(5):e0324628. doi: 10.1371/journal.pone.0324628. eCollection 2025.
2
Inhibition of RANKL improves the skeletal phenotype of adenine-induced chronic kidney disease in mice.抑制核因子κB受体活化因子配体(RANKL)可改善腺嘌呤诱导的小鼠慢性肾病的骨骼表型。
JBMR Plus. 2024 Jan 14;8(2):ziae004. doi: 10.1093/jbmrpl/ziae004. eCollection 2024 Feb.
3
Musculoskeletal Health Worsened from Carnitine Supplementation and Not Impacted by a Novel Individualized Treadmill Training Protocol.

本文引用的文献

1
Adenine-induced chronic kidney disease induces a similar skeletal phenotype in male and female C57BL/6 mice with more severe deficits in cortical bone properties of male mice.腺嘌呤诱导的慢性肾脏病在雄性和雌性 C57BL/6 小鼠中诱导出相似的骨骼表型,雄性小鼠的皮质骨特性缺陷更为严重。
PLoS One. 2021 Apr 23;16(4):e0250438. doi: 10.1371/journal.pone.0250438. eCollection 2021.
2
Strain-specific alterations in the skeletal response to adenine-induced chronic kidney disease are associated with differences in parathyroid hormone levels.腺嘌呤诱导的慢性肾脏病引起的骨骼反应的特异性改变与甲状旁腺激素水平的差异有关。
Bone. 2021 Jul;148:115963. doi: 10.1016/j.bone.2021.115963. Epub 2021 Apr 17.
3
肉碱补充剂会导致肌肉骨骼健康恶化,而新型个体化跑步机训练方案不会对此产生影响。
Am J Nephrol. 2024;55(3):369-379. doi: 10.1159/000537827. Epub 2024 Feb 20.
4
Assessing cortical bone porosity with MRI in an animal model of chronic kidney disease.用 MRI 评估慢性肾脏病动物模型的皮质骨多孔性。
Bone. 2023 Aug;173:116808. doi: 10.1016/j.bone.2023.116808. Epub 2023 May 18.
N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder.
N-乙酰半胱氨酸(NAC),一种抗氧化剂,不能改善进行性慢性肾脏病-矿物质和骨异常大鼠模型的骨力学性能。
PLoS One. 2020 Mar 23;15(3):e0230379. doi: 10.1371/journal.pone.0230379. eCollection 2020.
4
The global burden of chronic kidney disease.慢性肾脏病的全球负担。
Lancet. 2020 Feb 29;395(10225):662-664. doi: 10.1016/S0140-6736(19)32977-0. Epub 2020 Feb 13.
5
Elevations in Cortical Porosity Occur Prior to Significant Rise in Serum Parathyroid Hormone in Young Female Mice with Adenine-Induced CKD.在腺嘌呤诱导的 CKD 年轻雌性小鼠中,血清甲状旁腺激素显著升高之前,皮质骨孔隙率升高。
Calcif Tissue Int. 2020 Apr;106(4):392-400. doi: 10.1007/s00223-019-00642-w. Epub 2019 Dec 12.
6
Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBD.晚期糖基化终末产物(AGE)降低药物ALT-711对慢性肾脏病-矿物质和骨异常(CKD-MBD)大鼠模型生化、血管及骨骼参数的影响
J Bone Miner Res. 2020 Mar;35(3):608-617. doi: 10.1002/jbmr.3925. Epub 2019 Dec 30.
7
Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats.去卵巢对 Cy/+ 雌性大鼠慢性肾脏病-矿物质骨异常(CKD-MBD)进展的影响。
Sci Rep. 2019 May 28;9(1):7936. doi: 10.1038/s41598-019-44415-9.
8
Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study.甲状旁腺抑制治疗可使慢性肾脏病引起的皮质骨血管灌注升高恢复正常:一项初步研究。
Osteoporos Int. 2019 Aug;30(8):1693-1698. doi: 10.1007/s00198-019-04974-z. Epub 2019 May 8.
9
Time course of rapid bone loss and cortical porosity formation observed by longitudinal μCT in a rat model of CKD.CKD 大鼠模型中纵向 μCT 观察到的快速骨丢失和皮质多孔性形成的时程。
Bone. 2019 Aug;125:16-24. doi: 10.1016/j.bone.2019.05.002. Epub 2019 May 3.
10
Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.CKD 患者的骨折:欧洲钙化组织协会和欧洲肾脏协会肾脏病透析与移植分会成员的综述
Kidney Int. 2017 Dec;92(6):1343-1355. doi: 10.1016/j.kint.2017.07.021. Epub 2017 Sep 28.